HUE057788T2 - Eslikarbazepin szilárd orális dózisformái - Google Patents

Eslikarbazepin szilárd orális dózisformái

Info

Publication number
HUE057788T2
HUE057788T2 HUE16875035A HUE16875035A HUE057788T2 HU E057788 T2 HUE057788 T2 HU E057788T2 HU E16875035 A HUE16875035 A HU E16875035A HU E16875035 A HUE16875035 A HU E16875035A HU E057788 T2 HUE057788 T2 HU E057788T2
Authority
HU
Hungary
Prior art keywords
eslicarbazepine
dosage forms
oral dosage
solid oral
solid
Prior art date
Application number
HUE16875035A
Other languages
English (en)
Inventor
Ravikumar Nithiyanandam
Ganesh Vinayak Gat
Premchand Dalichandji Nakhat
Vivek Jain
Priyank Sharma
Dinesh Kumar
Baibhav Joshi
Kamal S Mehta
Original Assignee
Jubilant Generics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jubilant Generics Ltd filed Critical Jubilant Generics Ltd
Publication of HUE057788T2 publication Critical patent/HUE057788T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE16875035A 2015-12-18 2016-12-16 Eslikarbazepin szilárd orális dózisformái HUE057788T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN4163DE2015 2015-12-18

Publications (1)

Publication Number Publication Date
HUE057788T2 true HUE057788T2 (hu) 2022-06-28

Family

ID=59055907

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16875035A HUE057788T2 (hu) 2015-12-18 2016-12-16 Eslikarbazepin szilárd orális dózisformái

Country Status (6)

Country Link
US (2) US10918604B2 (hu)
EP (2) EP3402488B1 (hu)
ES (1) ES2903037T3 (hu)
HU (1) HUE057788T2 (hu)
PT (1) PT3402488T (hu)
WO (1) WO2017103876A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
US10918604B2 (en) * 2015-12-18 2021-02-16 Jubilant Generics Limited Solid oral dosage forms of eslicarbazepine
WO2019058354A1 (en) * 2017-09-25 2019-03-28 Jubilant Generics Limited SUSPENSION OF ESLICARBAZÉPINE
US11318145B2 (en) 2018-09-25 2022-05-03 Jubilant Generics Limited Eslicarbazepine suspension
WO2020130960A1 (en) * 2018-12-20 2020-06-25 Mustafa Nevzat Ilac Sanayi A.S. Oral pharmaceutical compositions of eslicarbazepine
HUP1900153A1 (hu) 2019-05-14 2020-11-30 Meditop Gyogyszeripari Kft Eszlikarbazepin-acetát tartalmú granulátum, ennek elõállítása, ezt tartalmazó egyéb gyógyszerkészítmények, és ezek alkalmazása
CN112546006B (zh) * 2020-12-25 2022-10-14 河北医科大学第二医院 一种治疗神经疾病的药物组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT101732B (pt) 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
AR048318A1 (es) 2004-03-22 2006-04-19 Novartis Ag Formulaciones de matriz orales que comprenden licarbazepina
US8372431B2 (en) * 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
TR201008460A1 (tr) * 2010-10-15 2012-05-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Eslikarbazepinin saşe formülasyonları.
UA115420C2 (uk) 2010-12-31 2017-11-10 Біал-Портела Енд Ка., С.А. Тверда фармацевтична композиція у формі гранул, що містить езлікарбазепіну ацетат
EP3103444A1 (en) * 2015-06-09 2016-12-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical compositions of lacosamide and eslicarbazepine
US10918604B2 (en) * 2015-12-18 2021-02-16 Jubilant Generics Limited Solid oral dosage forms of eslicarbazepine

Also Published As

Publication number Publication date
PT3402488T (pt) 2022-01-25
US20180280307A1 (en) 2018-10-04
US20210161823A1 (en) 2021-06-03
EP3402488A4 (en) 2019-08-14
US10918604B2 (en) 2021-02-16
EP3402488B1 (en) 2021-10-27
ES2903037T3 (es) 2022-03-30
WO2017103876A1 (en) 2017-06-22
EP3957302A1 (en) 2022-02-23
EP3402488A1 (en) 2018-11-21

Similar Documents

Publication Publication Date Title
IL287437A (en) Flavociclib solid dosage forms
ZA201700301B (en) Solid oral dosage form of lipophilic compounds
IL249946B (en) High Dose Strength Rocaprib Tablets
HUE044928T2 (hu) Ketamin orális dózisformája
HUE057788T2 (hu) Eslikarbazepin szilárd orális dózisformái
EP3346996A4 (en) ORAL PHARMACEUTICAL PHARMACEUTICAL FORM OF BUDESONID
PT3157506T (pt) Composição farmacêutica oral com sabor mascarado
ZA201700843B (en) Oral pharmaceutical composition of isotretinoin
GB201607548D0 (en) Solid dosage form
HRP20181406T1 (hr) Farmaceutski dozni oblici
HK1232144A1 (zh) 經口給藥用醫藥組合物
EP3167870C0 (en) TAMPER-PROOF ORAL DOSAGE FORM
IL252080B (en) Oral administration of drugs that are unstable or poorly absorbed
ZA201509174B (en) An oral medicinal composition